EUTOS Score for Chronic Myelogenous Leukemia (CML)

Predict outcomes after CML treatment, adjusted for tyrosine kinase treatments

The global unit selector only affects unanswered questions
1.Basophils
2.Spleen size
Created by

1. Basophils

%
Created by
0/2 completed

About this Calculator

The EUTOS Score was derived from a cohort of 2060 patients enrolled in studies of first-line treatment with imatinib-based regimens. The EUTOS score using the percentage of basophils and spleen size best discriminated between high-risk and low-risk groups of patients, with a positive predictive value of not reaching a CCgR of 34%.

References

Hasford J, Baccarani M, Hoffmann V, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R.

Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score.

2011 Jul 21;118(3):686-92. doi: 10.1182/blood-2010-12-319038. Epub 2011 May 2.

Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.